Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motion Sifnos
NCT03772340Phase 2Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Dec 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tradipitant in motion sickness, sponsored by Vanda Pharmaceuticals Inc.. Started Dec 2018; status: completed.
02
Drugs
tradipitant
03
Conditions
motion sickness
Beyond the preview
Go deeper on NCT03772340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03772340.